首页 | 本学科首页   官方微博 | 高级检索  
检索        

CT引导125Ⅰ粒子植入治疗非小细胞肺癌的剂量学验证
引用本文:李小东,郭永涛,王钦,张遵城,赵洪刚,董萍,董华.CT引导125Ⅰ粒子植入治疗非小细胞肺癌的剂量学验证[J].中华核医学杂志,2006,26(1):21-23.
作者姓名:李小东  郭永涛  王钦  张遵城  赵洪刚  董萍  董华
作者单位:300211,天津医科大学第二医院核医学科
摘    要:目的对125Ⅰ粒子植入治疗非小细胞肺癌进行剂量学验证.方法37例确诊的非小细胞肺癌患者,由放射治疗计划系统(TPS)通过CT引导植入125Ⅰ粒子,并行验证.定期进行复查.结果除2例无效外,1O例患者的病灶消失,25例明显缩小;瘤体的平均吸收剂量为150.5 Gy,匹配周缘吸收剂量(DMP)为86.6 Gy,靶区90%体积的吸收剂量(D90)为92.4 Gy,D90>DMP.结论125Ⅰ粒子植入治疗非小细胞肺癌安全可行.

关 键 词:  非小细胞肺  碘放射性同位素  近距离放射疗法  体层摄影术  X线计算机  放射治疗计划  计算机辅助
修稿时间:2005年8月17日

Dosimetric validation of 125Ⅰ seed implantation in non-small cell lung cancer guided by CT
LI Xiao-dong GUO Yong-tao WANG Qin.Dosimetric validation of 125Ⅰ seed implantation in non-small cell lung cancer guided by CT[J].Chinese Journal of Nuclear Medicine,2006,26(1):21-23.
Authors:LI Xiao-dong GUO Yong-tao WANG Qin
Institution:LI Xiao-dong GUO Yong-tao WANG Qin Department of Nuclear Medicine,Second Hospital,Tianjin Medical University,Tianjin 300211,China
Abstract:Objective To validate the dosimetry of ~(125)I seed implantation in non-small cell lung cancer(NSCLC)guided by CT.Methods ~(125)I seed was implanted in 37 cases confirmed NSCLC by the treatment planning system(TPS)and guided by CT image,then the radiation dose was validated and all ca- ses were fellow up in certain duration.Results Except no response in 2 cases,tumors disappeared in 10 cases and markedly shrinked in 25 cases.The average irradiated absorbed dose by the tumor was 150.5 Gy, whereas the matched peripheral dose(D_(MP))was 86.6Gy,and the irradiated absorbed dose of 90% target volume(D_(90))was 92.4 Gy thus D_(90)>D_(MP).Conclusion The therapy of ~(125)I seed implantation in NSCLC is safe and available.
Keywords:Carcinoma  non-small cell lung  Iodine radioisotopes  Brachytherapy  Tomography  X-ray computed  Radiotherapy planning  computer-assisted
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号